Clinical Trials on Pancreas Neuroendocrine Tumor in Japan
Total 372 results
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Boehringer IngelheimRecruitingNeuroendocrine NeoplasmsUnited States, Spain, Germany, Japan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
GlaxoSmithKlineCompleted
-
Wakayama Medical UniversityOsaka University; Kyoto Prefectural University of Medicine; Nara Medical University and other collaboratorsCompletedPancreatic Cancer | Chronic Pancreatitis | Pancreatic Cystic Lesions | Pancreatic Neuroendocrine Tumors | Pancreatic PseudocystsJapan
-
Keio UniversityMerck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.Recruiting
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
PfizerCompletedPancreatic Neuroendocrine TumorsJapan
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
Cancer Intelligence Care Systems, Inc.Stella Pharma CorporationCompletedAngiosarcoma | Malignant MelanomaJapan
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Osaka UniversityMerck Sharp & Dohme LLC; ISHIHARA SANGYO KAISHA,LTD. JapanUnknownAdvanced MelanomaJapan
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Daiichi Sankyo Co., Ltd.RecruitingTenosynovial Giant Cell TumorJapan
-
Hokkaido Pancreatobiliary Endoscopic Intervention...Hokkaido University HospitalCompleted
-
Chikara TashiroCompletedInflammatory Bowel Disease | Pancreas Disease | Hepatobiliary DiseaseJapan
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
GenmabBioNTech SERecruitingMalignant Solid TumorJapan
-
GenmabBioNTech SEActive, not recruiting
-
AstraZenecaCompleted
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminatedPancreatic Cancer | Pancreas NeoplasmsJapan
-
Novartis PharmaceuticalsTerminatedCancer | Solid Tumor | Advanced Solid TumorJapan
-
Takara Bio Inc.CompletedMelanoma Stage IV | Melanoma Stage IIIJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownPancreatic Cancer | Pancreas NeoplasmsJapan
-
Toshihiko DoiMerck Sharp & Dohme LLC; Oncolys BioPharma IncCompleted
-
Kyowa Kirin Co., Ltd.Ono Pharmaceutical Co. LtdCompleted
-
Institut de Recherches Internationales ServierNot yet recruitingMetastatic Adenocarcinoma of the PancreasJapan
-
Toray Industries, IncRecruiting
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
-
Daiichi Sankyo Co., Ltd.Recruiting
-
Eli Lilly and CompanyCompleted
-
Kohei ShitaraOno Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.CompletedAdvanced and Metastatic Solid TumorJapan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Ono Pharmaceutical Co. LtdCompletedMalignant Solid TumorJapan
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
AmgenCompletedUnresectable Stage IIIB-IV Malignant MelanomaJapan
-
SymBio PharmaceuticalsCompleted
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Takara Bio Inc.Completed
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted